News

Negotiations between EP and Council Presidency lead to top-up of €4 billion for Horizon Europe

Published on | 5 years ago

Programmes
Horizon 2020

Last Tuesday afternoon, after negotiations between the European Parliament budget negotiators and the German presidency of the European Council, a provisional agreement was reached on €16 billion extra for the next multiannual financial framework programme (2021-2027), of which € 4 billion for Horizon Europe. This comes on top of the budget agreed by the European Council on their July summit. The agreed compromise of last Tuesday will still need to be endorsed by the European Parliament and Council.

European Parliament press release

European Council press release

European Commission press release

Science Business article

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1795 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.